Epicore Biosystems Raises $26M Series B to Scale Its Sweat-Sensing Wearables and Cloud Analytics Platform

The funding will be used to advance global adoption and expand biomarker targets

CAMBRIDGE, Mass., Feb. 10, 2025 /PRNewswire/ — Epicore Biosystems (Epicore), a digital health solutions leader developing advanced sweat-sensing wearables, today announced that it has raised $26M in Series B funding led by the Steele Foundation for Hope (SFFH). The funding will help Epicore drive global adoption of its personalized hydration and cloud analytics platform and expand into new biomarker targets relevant to kidney health, women’s health, malnutrition and environmental toxin exposures.

Excessive heat exposure poses significant global challenges, particularly for individuals at the highest risk of heat injury, such as industrial workers, children, and expecting mothers. The threat of heat and the compounding effects of environmental toxins have been shown to result in acute health risks and chronic conditions at alarming rates. Epicore addresses these challenges with its sweat-sensing solutions that offer real-time insights into hydration, stress, nutrition and wellness. Epicore’s technology taps into the underlying biochemistry and metabolic health by measuring sweat composition and fluid losses, non-invasively, and in tandem with traditional digital biomarkers to alert when a wearer is at risk of heat injury, dehydration or malnutrition.

“Epicore has developed a new class of biochemical sensing wearables that enable the sports, fitness and connected worker sectors to unlock key health and wellness insights,” said Dr. Roozbeh Ghaffari, CEO and co-founder of Epicore Biosystems. “Our technology delivers data-driven recommendations to the wearer to help manage these types of challenges. The Series B investment will help expand our global reach and accelerate the validation of new biomarkers needed to shape the future of personalized hydration and wellness strategies for all.”

Epicore’s suite of sweat-sensing wearable solutions includes the Gx Sweat Patch, commercialized in partnership with PepsiCo and Gatorade, the Discovery Patch® Sweat Collection System (FDA Class I device) and the Connected Hydration wearable and cloud platform tailored for industrial workers.

“Epicore’s commitment to improving personalized health for those in critical need aligned strongly with our mission to improve the quality of life for people in need worldwide,” said Joe Exner, CEO of Steele Foundation for Hope. “We are proud to back Epicore’s pioneering work in sweat-monitoring technology, an innovation with significant potential to address the critical health challenges frontline populations face due to climate change.”

Since completing its Series A over three years ago, Epicore has expanded beyond sports and fitness and grown its customer base by 24x with leading multinational enterprises in the energy, construction, manufacturing and aviation sectors. With ever-growing health and environmental disparities, the need for connected digital solutions that measure advanced biometrics and provide personalized recommendations is driving a new health tech revolution.

To learn more about Epicore and its solutions, visit www.epicorebiosystems.com.

About Epicore Biosystems:
Epicore Biosystems is a digital health company spun out of Northwestern University’s Querrey Simpson Institute for Bioelectronics and the John Rogers Laboratory. Epicore has developed advanced sweat-sensing wearables that provide real-time personalized health insights. Their clinically validated biowearable solutions and cloud analytics are deployed globally and licensed by leading Fortune 500 companies, the Department of Defense and the National Institute of Health. To learn more, visit: https://www.epicorebiosystems.com/. Follow Epicore on LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/epicore-biosystems-raises-26m-series-b-to-scale-its-sweat-sensing-wearables-and-cloud-analytics-platform-302371475.html

SOURCE Epicore Biosystems, Inc.